Move to TSXShould patients 16, 17 & 18 demonstrate a majority or even all show 100 percent CR then the assumption can be made that most of the remaining patients to be given the optimized treatment will also have that result. We have heard in the past at some point Theralase will move from the Venture Exchange to the senior board TSX and also go after a Nasdaq listing, I would guess once 50 or 60 patients have proven this to be highly effective in the destruction of Cancer will we see that move or will that happen upon completion of Phase 2. Any thoughts?